AnJie Broad Law Firm is particularly impressive in providing patent protection; its wide array of capabilities extends to M&A, private equity investments and finance, frequently advising life sciences trials, medical institutions and testing laboratories. The team is jointly led by a capable trio, Hang Cai from the Shanghai office, alongside Beijing-based Ying Song and Nick Liu. Cai is sought out by leading private equity and venture capital firms for equity financing transaction expertise, while Song focuses on anti-monopoly and anti-unfair competition matters. Liu excels in IP litigation, arbitration, antitrust and competition cases.
Legal 500 Editorial commentary

Key clients

  • Suzhou Yiduoyun Health Co., Ltd.
  • Jiangsu Hengrui Pharmaceuticals Co., Ltd.
  • Suzhou Shengtuo Semiconductor Technology Co., Ltd.
  • Shanghai Ebos Biotechnology Co., Ltd.
  • ACON BIOTECH (HANG ZHOU) CO.LMT
  • Shanghai Healthcare Capital
  • LH Ventures capital
  • Fosun Pharma
  • 5Y Capital

Work highlights

Advised Shanghai Healthcare Capital in its USD 20 million Series B+ financing investment into Innostellar Biotherapeutics Co., Ltd., a gene therapy research and development company for ocular diseases.
Advised Long Hill Capital in InfinityWellness' series A++ financing.
Advised Jiangsu NHWA Pharmaceutical Co., Ltd for Cross-Border Pharmaceutical License Transactions.

Practice head

Ying Song; Hang Cai; Nick Liu